Results 261 to 270 of about 2,113,927 (314)

Antibody-Mediated Therapies in Urothelial Carcinoma: A Critical Narrative Review. [PDF]

Cancers (Basel)
Go SI, Xavier VFDC, Kang MH, Lee WS.
europepmc   +1 more source

Targeted β‐Glucan‐Veiled Oral Apremilast Nanotherapy Modulates Key Dysbiosis‐Associated Gut Microbiota and Alleviates Ulcerative Colitis‐Associated Anxiety, Depression, and Neuropsychiatric Behaviors

Advanced Science, EarlyView.
This study introduces β‐glucan‐shielded apremilast laden nanomicelles that withstand gastrointestinal degradation, selectively accumulate in inflamed colon tissue, and modulate the microbiota–gut–brain axis. The formulation restores barrier integrity, reduces systemic and neuroinflammation, and improves anxiety‐ and depression‐like behaviors in colitis
Chandrashekhar Jori, Ahmed Shaney Rehman, Taruna Lamba, Anas Ahmad, Jattin Kumar, Aneesh Ali, Ajesh Joshi, Ashraf Ali, Suhel Parvez, Javed N. Agrewala, Rehan Khan   +10 more
wiley   +1 more source

Proteomic identification and histopathological validation of candidate biomarkers CA1, HBB, Torsin A, and <i>α</i>-Tubulin in gingivo-buccal oral squamous cell carcinoma. [PDF]

Front Med (Lausanne)
Shyamsundar V, Ravindran S, Krishnamurthy A, Venugopal DC, Madhavan Y, Sivagnanam A, Nair AM, Vimal S, Kesavan P, Senthil Subramaniyan N, Aravindha Babu N, Ramshankar V.   +11 more
europepmc   +1 more source

The Immune Landscape of Chondrosarcoma: A Review of Tumor-Related Immune Cells. [PDF]

Cancers (Basel)
Silvaggio MT, Tabler CP, Basbay S, Weiss K, Schoedel K, Lohse I.   +5 more
europepmc   +1 more source

Mutual Information-based Prognostic Biomarker Discovery in Cancer Genomics: Conceptual Framework and Representative Applications of MI-POG. [PDF]

Cancer Genomics Proteomics
Akimoto K, Tamori S, Sato K.
europepmc   +1 more source

Approach to the patient: precision medicine-guided evaluation and treatment of acromegaly.

J Clin Endocrinol Metab
Puig-Domingo M, Marques-Pamies M, Sampedro M, Gil J, Araujo-Castro M, Martínez-Hernández R, Biagetti B, Jordà M, Valassi E, Marazuela M.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Biomarkers of neuroendocrine tumors

Annales de biologie clinique, 2016
Neuroendocrine tumors (NET) are rare heterogenous tumors which prevalence is increasing. Their features vary by anatomical location, functionality and hormonal production. Their management needs a multidisciplinary approach. Functional tumors develop characteristic clinical syndromes in contrast to non-functional tumors that are diagnosed fortuitously ...
Michèle, d'Herbomez, Lucie, Coppin, Catherine, Bauters, Nathalie, Rouaix-Emery, Bruno, Carnaille, Christine, Do Cao   +5 more
openaire   +2 more sources

Urinary Biomarkers in Tumors: An Overview

2021
Recent reports suggest that urine is a useful noninvasive tool for the identification of urogenital tumors, including bladder, prostate, kidney, and other nonurological cancers. As a liquid biopsy, urine represents an important source for the improvement of new promising biomarkers, a suitable tool to identify indolent cancer and avoid overtreatment ...
Ilaria, Cimmino, Sara, Bravaccini, Claudio, Cerchione   +2 more
openaire   +2 more sources

Biomarkers in airway tumors

International Journal of Oncology, 1996
Despite advances and improvements in diagnosis and treatment of upper aerodigestive tumors including head and neck and lung cancers, the overall survival rate of these patients remains poor. Prevention, early diagnosis, and novel therapy are under active investigation to improve the outcome of the diseases.
D, Shin, W, Hong
openaire   +2 more sources